ATH-1105 – A next-generation, novel, orally administered, small molecule drug candidate in development for the potential treatment of amyotrophic lateral sclerosis (ALS) and other neurodegenerative ...
A fundraiser has been launched for Will Vess, a 57-year-old retired United States Air Force veteran who was recently ...
54m
Completed enrollment of Phase 2 BESTOW trial of tegoprubart in kidney transplantation four months ahead of schedule; on track to report topline ...
Her husband, Scott Sessa, said that her death, in a hospital, was caused by complications of amyotrophic lateral sclerosis ...
Our pipeline includes programs for Alzheimer's disease, amyotrophic lateral sclerosis (ALS), Parkinson's disease, and ...
The event was initially reported as motor neuropathy, which was later defined as amyotrophic lateral sclerosis (ALS), a ...
The event was initially reported as motor neuropathy, which was later defined as amyotrophic lateral sclerosis (ALS), a ...
Galantamine slowed decline in cognitive function, functional ability, and behavior at 6 months in people with Alzheimer's ...
Amyotrophic lateral sclerosis (ALS) is the most common form of MND and there is currently no cure for the condition which ...
The FDA initially halted the trials on 16 October after a patient in the Phase II trial (NCT05519839) of the CIC vaccine ...
The FDA has lifted its clinical hold on Novavax's combined COVID-19 and influenza vaccine trial, finding no link between the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback